FDA issued a Warning Letter to Jajco, Inc. DBA Anchor Drugs Pharmacy on 8/22/2017 as a result of this inspection.
FDA investigators audited the Jajco DBA Anchor Drugs Pharmacy - South San Francisco, CA, United States facility and issued 7 inspectional observations (via FDA 483) on 03 Jun 2016.
Product details
- Category: Human Drugs
- Number of Observations: 7
- Inspection end: 03 Jun 2016
- Location: South San Francisco, United States
- FEI: 3012327563
